Management

Management

Lance M. Westerhoff, Ph.D.
Chief Executive Officer

Dr. Lance Westerhoff, PhD, was appointed as the new Chief Executive Officer of the Company effective March 1, 2024, after servicing as its President and General Manager for more than 15 years. An entrepreneur and computational biochemist, Dr. Westerhoff has been integral to the Company since its inception. His experience includes project management, leadership, software engineering and development, strategic planning, and fund raising efforts including securing angel, venture capital, and public/grant funding. Dr. Westerhoff is also a published scientist with projects involving the synergistic application of quantum mechanics and molecular mechanics in the life and pharmaceutical sciences. He has played a pivotal role in overseeing the research, development, and deployment of advanced technology within the Company, and has successfully marketed these tools to the pharmaceutical industry through his extensive contacts.